Abstract:It has been reported that the inhibitory postsynaptic potential (IPSP) is abolished before the excitatory postsynaptic potential (EPSP) when the extracellular concentration of Ca2+ ([Ca2+]o) is removed gradually in hippocampal slices. However, the low-Ca2+ nonsynaptic epileptiform activity does not appear until the [Ca2+]o is decreased to a level sufficient to depress the excitatory synaptic transmission. This suggests the hypothesis that the suppression of excitatory synaptic transmission itself could facilitate the generation of epileptiform activity. In the present study, we tested this hypothesis and developed a new model of nonsynaptic epileptiform activity by gradually raising the neuronal excitability and blocking the synaptic transmission with high K+, zero Ca2+ and calcium chelator ethylene glycol-bis (β-aminoethyl ether)-N,N,N′,N′-tetraacetic acid (EGTA) in the CA1 region of hippocampus in vivo. The changes of synaptic transmission and recurrent inhibitory activity during this process were evaluated by measuring the amplitude of the population spikes (PS) in response to paired-pulse orthodromic stimulation. The results show that the epileptiform activity appeared only when the excitatory synaptic transmission was depressed by further lowering [Ca2+]o with EGTA. Similar epileptiform activity could be induced when EGTA was replaced by the excitatory postsynaptic amino acid antagonists d-(−)-2-amino-5-phosphonopentanoic acid (APV) plus 6,7-dinitroquinoxaline-2,3-dione (DNQX) or APV alone but not DNQX alone. The combination application of APV and cadmium enhanced the epileptiform activity. These results suggest that the suppression of excitatory synaptic transmission can facilitate the appearance of epileptiform activity in solution with high K+ and low Ca2+ in vivo. These data provide new information to be considered in the development of antiepileptic drugs. They also suggest a possible mechanism to explain the fact that low-frequency electrical stimulation can suppress epileptiform activity.

Cordycepin Suppresses Excitatory Synaptic Transmission in Rat Hippocampal Slices Via a Presynaptic Mechanism

Cordycepin suppresses glutamatergic and GABAergic synaptic transmission through activation of A1 adenosine receptor in rat hippocampal CA1 pyramidal neurons

The metaplastic effects of cordycepin in hippocampal CA1 area of rats

Long-term Potentiation Alters the Modulator Pharmacology of AMPA-type Glutamate Receptors.

Neuroprotective effects of cordycepin inhibit glutamate-induced apoptosis in hippocampal neurons

[Metabolism of niflumic acid in man].

Hypertonic stimulation inhibits synaptic transmission in hippocampal slices through decreasing pre-synaptic voltage-gated calcium current.

Application of Overexcitation Model Induced by Penicillin Sodium in the Study of Inhibitory Effect of Sedative-Hypnotic Drugs.

The Quercetin-modulated Activity-dependent Inhibition of Endocytosis at a Central Synapse

Cordycepin Modulates Microglial M2 Polarization Coupled with Mitochondrial Metabolic Reprogramming by Targeting HKII and PDK2

Prognostic Biomarkers for Response to Vascular Endothelial Growth Factor-Targeted Therapy for Renal Cell Carcinoma.

Transient Receptor Potential Vanilloid 4 Mediates Hypotonicity-Induced Enhancement Of Synaptic Transmission In Hippocampal Slices

Suppression of Excitatory Synaptic Transmission Can Facilitate Low-Calcium Epileptiform Activity in the Hippocampus in Vivo

Cordycepin generally inhibits growth factor signal transduction in a systems pharmacology study

Cordycepin ameliorates cardiac hypertrophy via activating the AMPKα pathway

Cordycepin mitigates MPTP-induced Parkinson's disease through inhibiting TLR/NF-κB signaling pathway

Correlation between mEPSC Amplitude and Rise Time upon the Blockade of AMPA Receptor Desensitization at Hippocampal Synapses

Cordycepin confers neuroprotection in mice models of intracerebral hemorrhage via suppressing NLRP3 inflammasome activation

Role of excitatory amino acid receptors in synaptic transmission in area CA1 of rat hippocampus

Amoxapine Inhibits Delayed Outward Rectifier K+ Currents in Cerebellar Granule Cells Via Dopamine Receptor and Protein Kinase A Activation

Cordycepin protects renal ischemia/reperfusion injury through regulating inflammation, apoptosis, and oxidative stress